DcaP-Family Porins are Required for Carboxylic Acid Utilization and Infection in Acinetobacter baumannii

This study demonstrates that *Acinetobacter baumannii* relies on a redundant family of DcaP outer membrane porins to utilize essential carboxylic acids and establish infection in specific host niches, thereby validating these proteins as promising therapeutic targets.

The Gist

The Big Picture: A Bacterial Fortress and Its Secret Doors

Imagine Acinetobacter baumannii as a highly fortified castle. This bacterium is a notorious "superbug" that causes dangerous infections in hospitals. Like a castle, it has a thick outer wall (the outer membrane) designed to keep bad things out, like antibiotics and the body's immune system.

However, to survive and grow, the castle also needs to let good things in: food (nutrients). The problem is, this wall is so tough that it's hard for even the food to get through. The bacteria need special "gates" or "doors" to let specific nutrients inside.

This paper is about discovering and understanding a specific set of these gates, called DcaP porins. The researchers wanted to know:

1. What do these gates look like?
2. What kind of food do they let in?
3. Are they important for the bacteria to cause disease in humans?

---

1. The Four Types of Gates (The DcaP Family)

The researchers looked at the genetic blueprints of many different Acinetobacter bacteria. They found that these bacteria don't just have one type of gate; they have a whole family of them.

Think of these gates like a family of four different keys (let's call them Key 1, Key 2, Key 3, and Key 4).

• The Discovery: While other types of bacteria might have a generic "DcaP" key, Acinetobacter has evolved these four specific, specialized versions.
• The Pattern: Almost every Acinetobacter strain has at least two of these keys, and many have all four. It seems the bacteria really like having a backup plan.

2. What Do These Gates Open? (The Food Connection)

The scientists suspected these gates were used to bring in a specific type of food: carboxylic acids. Think of these as special energy drinks or fuel sources (like citric acid, which is in lemons, or tricarballylic acid).

To test this, they built a "locked" version of the bacteria where they removed all four keys (the triple mutant).

• The Test: They put the bacteria in a bowl with only these special acids as food.
• The Result: The bacteria without the keys starved. They couldn't grow.
• The Conclusion: These gates are essential for the bacteria to eat these specific acids. Without them, the bacteria can't get the fuel they need to survive in certain environments.

The "Redundancy" Twist:
Here is where it gets interesting. The researchers found that Key 3 (DcaP3) is the main worker. If you take away Key 3, the bacteria can't eat the food.

• However, if you take away Key 1, 2, or 4, the bacteria are fine because Key 3 is still working.
• But, if you take away all the keys, the bacteria are doomed.
• The Analogy: Imagine a house with four doors. Usually, only the front door (Key 3) is open. If you lock the front door, the family can't get in. But if you lock the back door (Key 1), it doesn't matter because the front door is still open. The doors are "redundant"—they can do the same job if the main one is gone, but they usually let the main one do the work.

3. The "Vaccine" Question (Are These Gates Good Targets?)

Because these gates are so important and sit right on the outside of the bacteria, scientists have been thinking about using them as a target for vaccines. The idea is: "If we make antibodies against these gates, we can block them, starve the bacteria, and stop the infection."

The researchers tested this by infecting mice with the bacteria.

• The Surprise: When they infected mice with the bacteria that had no gates at all, the bacteria were weaker in the liver and spleen. They couldn't cause as much damage.
• The Catch: However, when they infected mice with bacteria that only lacked Key 3, the bacteria were still just as dangerous as the wild type!
• Why? Because inside the human body (the "host"), the bacteria seem to wake up the other keys (Key 1, 2, or 4). They switch on the backup doors to get the food they need.

The Lesson for Medicine: If we want to make a vaccine or a drug that blocks these gates, we can't just block Key 3. We have to block all four keys at once, or the bacteria will just use the others to sneak in.

4. The "Sulbactam" Mystery

There was a previous theory that these gates might also be used by a specific antibiotic helper drug called sulbactam to get inside the bacteria. The researchers tested this by removing the gates and seeing if the bacteria became resistant to the drug.

• The Result: The gates didn't matter for this drug. The bacteria could still get the drug in through other ways. So, these specific gates aren't the main entry point for this antibiotic.

Summary: The Takeaway

• The Problem: Acinetobacter is a tough bug with a hard shell.
• The Solution: It uses a family of four special gates (DcaP1-4) to let in specific food (carboxylic acids).
• The Main Worker: Gate #3 (DcaP3) is the star player in the lab, doing most of the work.
• The Backup Plan: In the human body, the bacteria are smart. If Gate #3 is blocked, they open Gates 1, 2, or 4 to keep eating and causing infection.
• The Future: To stop this bacteria, we need to design treatments that block all these gates simultaneously, not just the main one.

This research helps us understand how these superbugs eat and survive inside us, giving scientists a better map for building new weapons against them.

Technical Summary

1. Problem Statement

Acinetobacter baumannii is a critical multidrug-resistant (MDR) pathogen causing healthcare-associated infections. Its outer membrane (OM) acts as a formidable barrier against antibiotics and host defenses, yet it must remain permeable enough to allow the uptake of essential nutrients. While the primary porin OmpA is known to be a slow transporter with a structural role, the specific mechanisms by which A. baumannii imports small molecule nutrients, particularly carboxylic acids, remain poorly understood.

Previous studies identified "DcaP-like" proteins (putative dicarboxylic acid porins) in Acinetobacter and proposed them as vaccine candidates. However, their specific biological roles, substrate specificities, and functional redundancy within the A. baumannii genome were unclear. Specifically, it was unknown if these proteins were essential for nutrient acquisition or if they played a role in virulence during infection.

2. Methodology

The authors employed a combination of comparative genomics, phylogenetics, microbiological assays, and in vivo infection models:

• Genomic and Phylogenetic Analysis:
  • Analyzed 250 deduplicated Acinetobacter genomes (235 A. baumannii) to classify DcaP-family proteins.
  • Used OrthoFinder and FastTree to construct phylogenetic trees, distinguishing between Acinetobacter-specific DcaP classes and orthologs in other bacterial genera (e.g., Shewanella, Xanthomonas).
• Strain Construction:
  • Generated a series of mutants in A. baumannii ATCC 17978 and the virulent clinical isolate AB5075.
  • Created single, double, and triple knockouts (e.g., $\Delta dcaP1\Delta dcaP2\Delta dcaP3$) to assess functional redundancy.
  • Constructed chromosomal complementation strains using mini-Tn7 vectors to express specific dcaP genes (1–4) under the dcaP3 promoter.
• Phenotypic Screening:
  • Biolog PM Plates: High-throughput screening to identify carbon sources supporting growth differences between wild-type (WT) and the triple mutant.
  • Growth Curves: Validated Biolog results using M9 minimal media with specific carboxylic acids (citric, tricarballylic, mucic, aconitic, succinic, butyric) as sole carbon sources.
  • Antibiotic Susceptibility: Tested susceptibility to ampicillin/sulbactam to verify if DcaP proteins facilitate sulbactam entry (a previous hypothesis).
• In Vivo Virulence Model:
  • Utilized a murine bloodstream infection model (Swiss Webster mice) inoculated retro-orbitally.
  • Compared bacterial burdens in the liver, spleen, lung, kidney, and heart between WT, the triple mutant, and complemented strains at 24 hours post-infection.

3. Key Contributions

• Classification of DcaP Proteins: The study defines four distinct classes of DcaP-family porins (DcaP1–4) specific to Acinetobacter, demonstrating that these classes diversified within the genus rather than being acquired from distant taxa.
• Functional Redundancy vs. Specificity: The paper elucidates the functional hierarchy among these porins, identifying DcaP3 as the primary transporter for specific substrates under laboratory conditions, while revealing significant functional overlap among DcaP1, DcaP2, and DcaP4 during infection.
• Substrate Specificity: It definitively links DcaP3 to the uptake of di- and tri-carboxylic acids (citric, tricarballylic, mucic, and aconitic acids), correcting previous assumptions about their role in sulbactam transport.
• Host Niche Adaptation: The study demonstrates that while DcaP3 is critical for growth on specific carbon sources in vitro, its role in vivo is compensated by other family members, highlighting the plasticity of nutrient acquisition strategies during infection.

4. Key Results

• Genomic Distribution: All surveyed A. baumannii genomes encode at least two DcaP genes, with many encoding all four classes. The four classes are widely conserved across pathogenic Acinetobacter but are distinct from DcaP-like proteins in other bacterial genera.
• Sulbactam Transport: Contrary to previous hypotheses, the triple $\Delta dcaP1-3$ mutant showed no increased resistance to ampicillin/sulbactam compared to WT, indicating DcaP proteins are not required for sulbactam uptake.
• Carbon Source Utilization:
  • The triple mutant ($\Delta dcaP1-3$) failed to grow on citric acid, tricarballylic acid, mucic acid, and cis/trans-aconitic acid.
  • DcaP3 was identified as the primary porin required for these substrates; single $\Delta dcaP3$ mutants exhibited the same growth defects as the triple mutant in in vitro conditions.
  • Complementation: Expressing dcaP2, dcaP3, or dcaP4 in the triple mutant restored growth on most substrates. dcaP1 only restored growth on aconitic acids, suggesting a more specialized or non-overlapping role.
• Virulence in Mice:
  • The triple mutant ($\Delta dcaP1-3$) was significantly attenuated in the liver and spleen compared to WT, but not in the lung, kidney, or heart.
  • Complementation: Expressing dcaP3 in the triple mutant restored virulence in the liver and spleen.
  • Redundancy in Host: Crucially, the single $\Delta dcaP3$ mutant showed no defect in virulence compared to WT. This indicates that during infection, other DcaP proteins (likely DcaP1 or DcaP2) are upregulated or functionally active to compensate for the loss of DcaP3.

5. Significance

• Nutrient Acquisition Mechanism: The study provides the first experimental evidence that DcaP-family porins are essential gatekeepers for di- and tri-carboxylic acids in A. baumannii, a capability critical for survival in nutrient-limited host environments (e.g., the liver and spleen where citric acid is abundant).
• Therapeutic Targeting: While DcaP3 has been a leading vaccine candidate, this study reveals that targeting a single DcaP protein may be insufficient due to functional redundancy during infection. Effective therapeutic strategies (vaccines or inhibitors) would likely need to target multiple DcaP family members simultaneously to block nutrient uptake and attenuate virulence.
• Evolutionary Insight: The findings suggest that the expansion of the DcaP family within Acinetobacter is an evolutionary adaptation to diverse environmental niches, allowing the pathogen to maintain metabolic flexibility and robustness against host defenses.

In summary, this paper redefines the understanding of the DcaP family in A. baumannii, moving from a view of a single porin to a complex, redundant system essential for nutrient scavenging and pathogenesis, with important implications for the design of future anti-virulence therapies.